With the first financial quarter of the year wrapping up at the end of March, i's finally time for the big publishers to reveal whether they met their sales targets. For Capcom, it's a touchy subject.
Releasing the figures to stockholders today, most of Capcom's bigger titles of the last few months fell short of expectations. Some would say their predictions were too high whereas others might boil it down to a sign of the times or Capcom's decision making with its niche titles.
Despite a very strong reception and the courage to take it back to its roots, Resident Evil 7 - released in January - skirted close to sales projections, but faltered at the finish line landing on 3.5 million of its 4 million goal. Similarly, Monster Hunter XX fell 300,000 units short of its 2 million goal. Dead Rising 4, however, fell well below. Expected to shift 2 million units across the Xbox One and Windows 10 platforms, all Capcom would say is that it didn't even hit half of that.
With Resident Evil (and Monster Hunter) just missing out on their sales predictions, Capcom remain optimistic. The issue with Resident Evil 7 likely boils down to its target audience more than its worth. Horror titles are a difficult sell with a good chunk of its social media buzz likely coming from the culture of watching streamers be scared by its contents rather than an increased amount of players picking up the game to experience it first-hand. Dead Rising 4, on the other hand, likely suffered from mediocre reviews and a late Steam launch above all else.
But it wasn't all bad news for the prolific Japanese publisher. The recently release Resident Evil remasters have surpassed 4 million combined sales with some older titles still moving decent amount. Now it's a case of looking out for the Q2 results in July.